Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Sartorius AG
  6. Summary
    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 09/28 03:56:50 pm
584 EUR   -9.03%
09/27SARTORIUS : To Open New Plant In Michigan, US
MT
09/23SARTORIUS VORZUEGE : JP Morgan reiterates its Buy rating
MD
09/20SARTORIUS VORZUEGE : DZ Bank sticks Neutral
MD
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
09/22/2021 09/23/2021 09/24/2021 09/27/2021 09/28/2021 Date
651(c) 690(c) 649(c) 642(c) 592(c) Last
2 502 4 501 6 188 4 347 10 104 Volume
-0.76% +5.99% -5.94% -1.08% -7.79% Change
More quotes
Estimated financial data (e)
Sales 2021 3 365 M 3 932 M 3 932 M
Net income 2021 422 M 493 M 493 M
Net Debt 2021 1 819 M 2 125 M 2 125 M
P/E ratio 2021 105x
Yield 2021 0,21%
Sales 2022 3 680 M 4 300 M 4 300 M
Net income 2022 472 M 552 M 552 M
Net Debt 2022 1 517 M 1 773 M 1 773 M
P/E ratio 2022 94,8x
Yield 2022 0,23%
Capitalization 38 670 M 45 164 M 45 182 M
EV / Sales 2021 12,0x
EV / Sales 2022 10,9x
Nbr of Employees 11 981
Free-Float 36,2%
More Financials
Company
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers... 
More about the company
Ratings of Sartorius AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about SARTORIUS AG
09/27SARTORIUS : To Open New Plant In Michigan, US
MT
09/23SARTORIUS VORZUEGE : JP Morgan reiterates its Buy rating
MD
09/20SARTORIUS VORZUEGE : DZ Bank sticks Neutral
MD
09/20SARTORIUS AKTIENGESELLSCHAFT(XTRA : SRT) added to FTSE All-World Index
CI
09/20SARTORIUS AKTIENGESELLSCHAFT(XTRA : SRT3) added to Germany DAX Index (Performance)
CI
09/17SARTORIUS AKTIENGESELLSCHAFT(XTRA : SRT3) dropped from Germany MDAX Index (Performance)
CI
09/16SARTORIUS : Opens Upgraded Application, Service Hub In Shanghai, China
MT
09/16Sartorius Opens New Application and Service Hub in Zhangjiang Science City in Shanghai,..
CI
09/06GLOBAL MARKETS LIVE : Puma, Boeing, Holcim, Revolut, Amazon...
09/05Airbus, Nine Others to Join Germany's DAX Index
MT
09/03Porsche, Puma to join Germany's DAX as index expands
RE
09/02FACTBOX-Key changes in shake-up of Germany's blue-chip DAX index
RE
07/29SARTORIUS VORZUEGE : DZ Bank gives a Neutral rating
MD
07/29SARTORIUS : Snaps Up German Cell Culture Company Xell
MT
07/28SARTORIUS VORZUEGE : Gets a Neutral rating from NorldLB
MD
More news
News in other languages on SARTORIUS AG
03:40aEckert & Ziegler geraten weiter unter Druck - Sartorius auch
09/27Sartorius va ouvrir une nouvelle usine dans le Michigan, aux États-Unis
09/27Sartorius errichtet neuen Standort in Michigan
09/20MÄRKTE EUROPA/Evergrande-Krise löst Kursrutsch aus
09/20XETRA-SCHLUSS/Neuer DAX mit Startproblemen - Evergrande verdirbt Stimmung
More news
Analyst Recommendations on SARTORIUS AG
More recommendations
Stock Trading Strategies
SARTORIUS AG - 07/28
No turn-around in sight
BUY
More Stock Trading Analysis
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | SRT | DE0007165607 | MarketScreener
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Last Close Price 592,00 €
Average target price 382,92 €
Spread / Average Target -35,3%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chief Executive Officer
Rainer Lehmann Chief Financial Officer
Lothar Kappich Chairman-Supervisory Board
Oscar-Werner Reif Head-Research & Development
Volker Niebel Head-Production, Procurement & Business Operations
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS AG71.59%47 707
BIOTAGE AB (PUBL)73.81%1 810
REVENIO GROUP OYJ6.96%1 731
CELLAVISION AB (PUBL)32.77%1 117
VAREX IMAGING CORPORATION67.27%1 100
ANGLE PLC163.87%386